Company Filing History:
3 out of 16 
2 out of 260 
Years Active: 2022-2024
Title: Ki Su Kim: Innovator in Biomedical Research
Introduction
Ki Su Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic agents. With a total of 3 patents to his name, Kim's work focuses on addressing critical health challenges.
Latest Patents
One of Ki Su Kim's latest patents is titled "Fusion protein comprising IDS and use thereof." This invention describes an asymmetric fusion protein that combines a fragment of an antibody binding to an insulin receptor, an iduronate-2-sulfatase (IDS) enzyme, and an Fc region. This fusion protein is notable for its ability to cross the blood-brain barrier (BBB), allowing for the delivery of the IDS enzyme to the brain. Consequently, a pharmaceutical composition containing this fusion protein can serve as a therapeutic agent for central nervous system diseases, particularly in preventing and treating conditions caused by ribosome accumulation.
Another significant patent is "Anti-CD3 antibody and pharmaceutical composition for cancer treatment comprising same." This invention relates to an anti-CD3 antibody that exhibits high affinity and specificity for CD3. As a result, it can be effectively utilized in the prevention or treatment of cancer.
Career Highlights
Throughout his career, Ki Su Kim has worked with esteemed organizations such as the Mogam Institute for Biomedical Research and the Green Cross Corporation. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.
Collaborations
Ki Su Kim has collaborated with notable colleagues, including Eun Jung Song and Hyung Kwon Lim. These partnerships have further enriched his research endeavors and have played a role in the success of his inventions.
Conclusion
Ki Su Kim is a distinguished inventor whose work in biomedical research has the potential to transform therapeutic approaches for various diseases. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.